Enzymes, Signaling Proteins, Extracellular Ligands, Signaling Reagents, Antibodies

Name	Catalog Number	CAS Registration Number	Molecular Formula	Purity	Chemical Name
2’-Deoxy-5-fluorocytidine	D353-904D	10356-76-0	C₉H₁₂FN₃O₄	>98%	5-Fluoro-2’-deoxycytidine; FCDR; FdCyd; NSC-48006
5-Azacytidine	D353-904	320-67-2	C₈H₁₂N₄O₅	>98% (TLC)	4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one, Ladakamycin
AK-7	S36-904	420831-40-9	C₁₉H₂₁BrN₂O₃S	98% (TLC)	N-(3-Bromophenyl)-3-[(hexahydro-1H-azepin-1-yl)sulfonyl]benzamide
APICIDIN	H83-904B	183506-66-3	C₃₄H₄₉N₅O₆	≥98%	Cyclo[(2S)-2-Amino-8-oxodecanoyl-1-methoxy-L-tryptophyl-L-isoleucyl-(2R)-2-piperidinecarbonyl]
BIX-01294 3HCl	S344-903	935693-62-2	C₂₈H₃₈N₆O₂.3HCl	>98%	2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine trihydrochloride
BML-210	H83-904C	537034-17-6	C₂₀H₂₅N₃O₂	98%	N1-(2-aminophenyl)-N8-phenyloctanediamide
C-646	K311-903	328968-36-1	C₂₄H₁₉N₃O₆	>98%	4-[4-[[5-(4,5-Dimethyl-2-nitrophenyl)-2-furanyl]methylene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzoic acid
Chaetocin	K421-904C	28097-03-2	C₃₀H₂₈N₆O₆S₄	>99%	Lys methyltransferase inhibitor
CPTH2	K311-903B	357649-93-5	C₁₄H₁₄ClN₃S	>98% (TLC)	Cyclopentylidene-[4-(4’-chlorophenyl)thiazol-2-yl]hydrazone
CUDC-101	H83-904	1012054-59-9	C₂₄H₂₆N₄O₄	>99% (HPLC)	7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide
Daminozide	K421-904B	1596-84-5	C₆H₁₂N₂O₃	98%	1-(2,2-Dimethylhydrazide)butanedioic acid
Decitabine	D353-904B	2353-33-5	C₈H₁₂N₄O₄	>98%	5-Aza-2’-deoxycytidine; NSC-127716
DMOG	J48-904	89464-63-1	C₆H₉NO₅	>98%	N-(2-Methoxy-2-oxoacetyl)glycine methyl ester; Dimethyloxalylglycine
EX-527	S35-904F	49843-98-3	C₁₃H₁₃ClN₂O	98% (TLC)	6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide (racemic)
Garcinol	K311-903C	78824-30-3	C₃₈H₅₀O₆	>97% (TLC)	Camboginol, 3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methyl-2-buten-1-yl)-5-[(2S)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-bicyclo[3.3.1]non-3-ene-2,9-dione
GSK-J1 (Free acid)	J48-904B	1373422-53-7	C₂₂H₂₃N₅O₂	99%	N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine
GSK-J4 (ethylester)	J48-904C	1373423-53-0	C₂₄H₂₇N₅O₂	>99%	N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine ethyl ester
HPA (HEXYL-4-PENTYNOIC ACID)	H83-904D	96017-59-3	C₁₁H₁₈O₂	>97% (TLC)	2-(2-propynyl)octanoic acid (racemic); HPA
IOX1 (8H5QCA)	J48-904D	5852-78-8	C₁₀H₇NO₃	>98% (HPLC)	5-Carboxy-8-hydroxyquinoline, 8-Hydroxy-5-quinolinecarboxylic acid
ML-324	J48-904E	1222800-79-4	C₂₁H₂₃N₃O₂	>98% (TLC)	N-(3-(dimethylamino)propyl)-4-(8-hydroxyquinolin-6-yl)benzamide
MS-275 (Entinostat)	H83-904E	209783-80-2	C₂₁H₂₀N₄O₃	>98% (TLC)	Pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate; Entinostat
Panobinostat	H83-904G	404950-80-7	C₂₁H₂₃N₃O₂	>98% (TLC)	(E)-N-hydroxy-3-(4-((2-(2-methyl-1H-indol-3-yl)ethylamino)methyl)phenyl) crylamide; LBH-589
Phenylbutyrate NA	H83-904H	1716-12-7	C₁₀H₁₁NaO₂	>98% (TLC; 5% CH3OH in CH2Cl2, Rf=0.36)	4-Phenylbutyric acid, sodium salt
RG-108	D353-904C	48208-26-0	C₁₉H₁₄N₂O₄	>98% (TLC)	N-Phthalyl-L-tryptophan
Romidepsin (FK228)	H83-904I	128517-07-7	C₂₄H₃₆N₄O₆S₂	>98% (HPLC)	Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl], cyclic (3-5) disulfide
Sirtinol	S35-904B	410536-97-9	C₂₆H₂₂N₂O₂	>98% (TLC)	2-[[(2-Hydroxy-1-naphthalenyl)methylene]amino]-N-(1-phenylethyl)benzamide
Splitomicin	S35-904G	5690-03-09	C₁₃H₁₀O₂	>98% (TLC)	1,2-Dihydro-3H-naphtho[2,1-b]pyran-3-one
TC-E 5003	P3695-903	17328-16-4	C₁₆H₁₄Cl₂N₂O₄S	>98% (TLC)	N,N’-(Sulfonyldi-4,1-phenylene)bis(2-chloroacetamide)
Tranylcypromine	K421-904	13492-01-8	C₉H₁₁N · 1/2H₂SO₄	>98% (TLC)	Trans (±)-2-phenylcyclopropanamine; 2-PCPA
Trichostatin A	H83-904J	58880-19-6	C₁₇H₂₂N₂O₃	>99%	(2E,4E,6R)-7-(4-(Dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide
Tubastatin A · HCL	H83-904K	1239262-52-2	C₂₀H₂₁N₃O₂·HCl	99% (HPLC)	N-hydroxy-4-((2-methyl-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)methyl)benzamide hydrochloride
UNC1999	D353-904E	1431612-23-5	C₃₃H₄₃N₇O₂	>98% (HPLC)	N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-1-propan-2-yl-6-[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]indazole-4-carboxamide
Valproate NA	H83-904L	1069-66-5	C₈H₁₅NaO₂	>98% (TLC)	Sodium 2-propylpentanoate
Vorinostat (SAHA)	H83-904M	149647-78-9	C₁₄H₂₀N₂O₃	>98%	N-Hydroxy-N’-phenyloctanediamide

Compounds

Compounds

Compounds

Compounds

Subscribe to our mailing list!